0
0.0
Aug 7, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
>> amgen, a disappointment on the weight loss.ius, which is younger people, that's the energy drink that makes claims that it's really good for you. we have cvs, karen lynch did a great job on retail. so i'm not willing to throw the baby out with the bath water and then rick muncrief wants to talk about gas. >> good show. >> that was one of the reasons i was up last night -- >> one of the many reasons you were uplast night. >> yeah. aside from my general insomnia. the only person who sleeps less than me is george kirks. who won le mans. >> don't take any naps between now and mad money. >> microsoft, crowd strike said delta didn't do the job. tya sanot a man i would mess with. velvet glove, real fist. >> we're staying on top of the rally this morning, don't go anywhere. no refrigeration, no heating or air conditioning. the winds are not letting up at all here. we're going to see some power outages. number one thing to prepare for is extended power outages. are you prepared? you can be with a generac home standby generator. when a p
>> amgen, a disappointment on the weight loss.ius, which is younger people, that's the energy drink that makes claims that it's really good for you. we have cvs, karen lynch did a great job on retail. so i'm not willing to throw the baby out with the bath water and then rick muncrief wants to talk about gas. >> good show. >> that was one of the reasons i was up last night -- >> one of the many reasons you were uplast night. >> yeah. aside from my general insomnia....
0
0.0
Aug 3, 2024
08/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
we know amgen could be a competitor.nd so this is, i guess, the crucial time when you have to make investment decisions, when prices are high and you have more cash coming in. is that how you view it? lars: yes. to put a bit of color around it, the same forecast predicts that there will be, say, a billion people living with obesity in 3035. we are perhaps serving one million or two million of those today. so, there is a huge market opportunity, and there is a place for more. and then, you're right, that in most markets when you get more competition, and also over time, pricing starts moving down, because you start treating those who accept, say, the higher price point -- in the u.s., that's commercial insurance -- and then, over time, you get broader access, and you get patients paying a lower price. so if you just take our leading diabetes product in the u.s., since launch in 2018, the price we get after rebates, discounts, etc. is some 40% lower than when we launched. that is often not mentioned in, say, the political
we know amgen could be a competitor.nd so this is, i guess, the crucial time when you have to make investment decisions, when prices are high and you have more cash coming in. is that how you view it? lars: yes. to put a bit of color around it, the same forecast predicts that there will be, say, a billion people living with obesity in 3035. we are perhaps serving one million or two million of those today. so, there is a huge market opportunity, and there is a place for more. and then, you're...
0
0.0
tv
eye 0
favorite 0
quote 0
. >> i'm speaking of biotech we talked about before i'm talking about amgen which is earnings next weekless than 1% this week it is supposed to have good numbers as a 3% dividend yield looks pretty good. all about parma and recession resistant. check out this week's edition of barron's.com. before we go we have to acknowledge how relieved and overjoyed we are to have a colleague evan gershkovich back on u.s. soil he was released after 491 days as part of a prisoner swap this week in a display of true fearlessness he left requesting russia for an interview with vladimir putin, that is all for us we will see you next week on "barron's roundtable". kelly: crypto is becoming a huge issue that could move the needle a
. >> i'm speaking of biotech we talked about before i'm talking about amgen which is earnings next weekless than 1% this week it is supposed to have good numbers as a 3% dividend yield looks pretty good. all about parma and recession resistant. check out this week's edition of barron's.com. before we go we have to acknowledge how relieved and overjoyed we are to have a colleague evan gershkovich back on u.s. soil he was released after 491 days as part of a prisoner swap this week in a...
0
0.0
Aug 31, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
. >> jeffries had a nice know of other players in the weight loss market, amgen is a giant with glp-1n phase two trials, before phase three and two others with phase two that are smaller companies structure therapeutics and biking therapeutics. beyond this particular obesity problem, the healthcare industry is really coming back to life in the stock market after quite a few bad years, what is driving the. >> was interesting there hasn't been anything except obesity working but now we see the stocks are actually rallying that a very good three months and is largely because of interest rates come about tech stocks are making money at the need to have access to cash and lower interest rate and the cash is cheaper. that is a good thing. but there are also treatments that are worth watching and other stocks are worth watching and they don't have obesity drugs, one that i like before his gilead sciences, gilead has an hiv treatment that is very big in the business and a new treatment that you don't take is often which could be a big hit, there's one called vertex which is a non- opioid pain
. >> jeffries had a nice know of other players in the weight loss market, amgen is a giant with glp-1n phase two trials, before phase three and two others with phase two that are smaller companies structure therapeutics and biking therapeutics. beyond this particular obesity problem, the healthcare industry is really coming back to life in the stock market after quite a few bad years, what is driving the. >> was interesting there hasn't been anything except obesity working but now...
0
0.0
Aug 2, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the biggest readout outside of novo and lilly is amgen with encouraging phase two results.to this and more with the interview for pro subscribers available on cnbc.com/pro later today. >> this is an interesting discussion. it has been comedominating the healthcare chatter. why is there still so much optimism with the drugs running massively? >> we are at the early stages of the market. there are two drugs available, but so much room left to go. this could be a possible $100 billion plus market. there is, of course, the u.s. and other countries around the world. we want to see pills. we want to see different amounts of weight loss. there's a lot of room left to run. that's why you are seeing so many companies getting into the space and still a lot more work from novo and lilly. >> angelica peebles, thank you very much. >> thank you, dom. >>> still ahead, the one word every investor needs to know today and the job report following the red wave in the market. we will get more on the landscape when "worldwide exchange" returns after this break. what is cirkul? cirkul is what yo
the biggest readout outside of novo and lilly is amgen with encouraging phase two results.to this and more with the interview for pro subscribers available on cnbc.com/pro later today. >> this is an interesting discussion. it has been comedominating the healthcare chatter. why is there still so much optimism with the drugs running massively? >> we are at the early stages of the market. there are two drugs available, but so much room left to go. this could be a possible $100 billion...
0
0.0
Aug 8, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
you have novo and lilly and viking and amgen.see a world with neurological disorders or other areas. >> what's next with the pharma space? novo made a lot of moves. what is the next thing for these on growth drivers? >> great question. we think we are still early in the journey. novo reported 2% of obesity cases in the world are treated with glp-1 drugs. looking beyond weight loss, we think knewneuro, the alzheimer'd others, we believe it could be used for disorders. >> the next blockbuster is the different use for the glp-1? >> correct. and eli lilly is reinvesting the money from the glp-1 into the capacity and new extension into other products. >> maurtis pot from temu etf. thank you for coming in. >> thanks for having me. >>> what some are calling the good news and bad news market. bob pinisa lays it out and the next move. we'll be right back. dave's company just scored the comcast business 5-year price lock guarantee. high five! high five! -i'm in a call... it's 5 years of reliable, gig speed internet... five years of advance
you have novo and lilly and viking and amgen.see a world with neurological disorders or other areas. >> what's next with the pharma space? novo made a lot of moves. what is the next thing for these on growth drivers? >> great question. we think we are still early in the journey. novo reported 2% of obesity cases in the world are treated with glp-1 drugs. looking beyond weight loss, we think knewneuro, the alzheimer'd others, we believe it could be used for disorders. >> the...
0
0.0
Aug 26, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
. ♪ stuart: goldman sachs, boeing, amgen, they're all down.g stone looking at san diego for future street races. synergy home san diego, ash? ashley: it's a city more famous for surfers and nascar thinks it's a perfect place for scars speeding around through downtown streets and they're looking to expand to urban areas with temporary circuits and tracks being used for decades and nascar held street races in chicago, sources say san diego, one of the cities of this race group is really targeting, other cities maybe considered talking to cincinnati, baltimore and some cities in the pacific northwest. look, formula 1 has street racing in the u.s. so why not nascar? stu? stuart: the thing about san diego is the weather is always good. 300 day as year, 72 and sunny. ashley: beautiful. stuart: u.s. open begins today. gerri willis in flushings, queens. how much money does a major sporting event like this bring in, the u.s. open? how much? reporter: get read ready: $1.5 billion. u.s. open starting today, day number one. we're here right in front of th
. ♪ stuart: goldman sachs, boeing, amgen, they're all down.g stone looking at san diego for future street races. synergy home san diego, ash? ashley: it's a city more famous for surfers and nascar thinks it's a perfect place for scars speeding around through downtown streets and they're looking to expand to urban areas with temporary circuits and tracks being used for decades and nascar held street races in chicago, sources say san diego, one of the cities of this race group is really...
0
0.0
Aug 19, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
5th bottom and let's take a look at the major indexes and s&p 500 up 227 points and health care like amgen united health are strong, as well. the nasdaq, good, lagging a little bit here as tech is not necessarily the leader today. the s&p 500 up eight days in a row along with the nasdaq, as well. look at the sector leaders here. energy, consumer discretionary, utilities, real estate and health care. these are generally with the exception of consumer discretionary and more defensive-type names and even cyclicals in the case of energy here and -- big-cap tech is on the mixed side today. semis were notably weak earlier and they recovered in the middle of the day and overall the tech rally appears to have stalled out with the biggest cap tech stocks that you have out there. a lot of consumer stocks that are leading the way. i mentioned mcdonald's earlier has had a great run recently and clorox, mohawk, for example, and homebuilders like lennar and outto utilities like edison as well as yield plays. i mentioned the s&p 500 up eight straight sessions and that's very unusual and this is the longe
5th bottom and let's take a look at the major indexes and s&p 500 up 227 points and health care like amgen united health are strong, as well. the nasdaq, good, lagging a little bit here as tech is not necessarily the leader today. the s&p 500 up eight days in a row along with the nasdaq, as well. look at the sector leaders here. energy, consumer discretionary, utilities, real estate and health care. these are generally with the exception of consumer discretionary and more defensive-type...
0
0.0
Aug 12, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
home depot in goldman salesforce and amgen all dragging down the dow the biggest losers on the dow taken to get a couple hundred points. the ten year treasury has been moving up you are down a bit, 393, the price of oil in the upper 70s, 7796. bitcoin is at $58000 per coin as markets are not a manic monday so far. now this . . . but harris is on a roll, this honeymoon has legs. a new york times poll shows the vice president leads by four points in three keys date michigan, pennsylvania and wisconsin, were sport trump according to a financial times poll more people trust harris on the economy that had been his strong suit. she is getting by with platitudes, vaguely saying she will work for the working people, make the economy work for everyone i have no idea what that means. she is flip-flopping on the border and on fracking but at this point does not matter kamala harris is playing a wave of emotion, democrats have had to do candidate who they think has a shot at winning and they're not going to mess things up by doing press conferences or interviews a serious journalist. besides harris
home depot in goldman salesforce and amgen all dragging down the dow the biggest losers on the dow taken to get a couple hundred points. the ten year treasury has been moving up you are down a bit, 393, the price of oil in the upper 70s, 7796. bitcoin is at $58000 per coin as markets are not a manic monday so far. now this . . . but harris is on a roll, this honeymoon has legs. a new york times poll shows the vice president leads by four points in three keys date michigan, pennsylvania and...
0
0.0
tv
eye 0
favorite 0
quote 0
cheryl: we'll hear from caterpillar, amgen and disney, dow components this week.ggest report so far that i've seen that really kind of got me concerned was the mcdonald's report. when you see the low income consumer concerned about prices at mcdonald's, that's when i think you've got an economic problem. but you're right, it's all data dependent but we'll see what happens a. adam, thank you very much for being here. >> thanks for having me. cheryl: all right. we have a lot more coming up. so the united states is expanding its controversial online app, that allows illegal migrants to cross the border easily. ohio congressman, house foreign affairs committee member warren davidson is next with his thoughts. you're watching "mornings with maria" live on fox business. we are continuing to follow a global market selloff all morning long. ♪ there are many ways to do things. at old dominion freight line, we do them this way. this way has people who start early. people who care and inspire each other to do things the way they should be done. this way uses technology (♪) a
cheryl: we'll hear from caterpillar, amgen and disney, dow components this week.ggest report so far that i've seen that really kind of got me concerned was the mcdonald's report. when you see the low income consumer concerned about prices at mcdonald's, that's when i think you've got an economic problem. but you're right, it's all data dependent but we'll see what happens a. adam, thank you very much for being here. >> thanks for having me. cheryl: all right. we have a lot more coming up....
0
0.0
Aug 12, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen's quarter was the big disappointment of the pharmacies.ly has a great plan and their drug is better than novo nordisk. theirs is more effective than novo nordisk. >> jim, have we really seen a food company where we feel like they have said, we're seeing an absolute effect or a restaurant company from -- >> not one. >> none. not one >> not one. and look, it is true that there's -- i mean, it's not like there's 20 million people on it. but not one, because who would ever admit to that? >> i know. and yet -- >> hey, our business is being killed by something that's really great for you. go get this because it's better than our food? no one wants to admit it, but they all seem to have data, and i mean this. pepsico had data before and after, and they did a lot of focus groups, and that's frito-lay, and ramon definitely showed me, jim, you're wrong, and i believe it. his data is so impeccable. >> his data indicating that there has not been an impact from the use of glp-1s? >> no impact. >> and as they become more broadly used through the populat
amgen's quarter was the big disappointment of the pharmacies.ly has a great plan and their drug is better than novo nordisk. theirs is more effective than novo nordisk. >> jim, have we really seen a food company where we feel like they have said, we're seeing an absolute effect or a restaurant company from -- >> not one. >> none. not one >> not one. and look, it is true that there's -- i mean, it's not like there's 20 million people on it. but not one, because who would...
0
0.0
Aug 19, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
we've got mcdonald's, intel, walt disney, amgen and travelers. evercore isi raising mcdonald's price target from $300 to 320 and we have it at 287 and change so these market gains that you see across-the-board come ahead of federal reserve chair jay powell's big speech this friday. you heard charles say it matters. it's really important. he will be at the central bankers forum in jackson hole where he's expected to widely signal a september rate cut, and after the last and latest read on consumer inflation, july's cpi came in below 3% for the first time since 2021 what does it all mean for stocks and the economy? let's get to the floor show joining me now live from the dnc in chicago is fox contributor and former ubs america's chairman and ceo robert wolf and with me here, pence wealth management cio drydon pence. robert, an eight day winning streak for the markets, inflation cooling that helped the narrative. real tailwinds for the democrats but this just as the dnc has its curtain raised. kamala harris and her price controls policy is suddenly
we've got mcdonald's, intel, walt disney, amgen and travelers. evercore isi raising mcdonald's price target from $300 to 320 and we have it at 287 and change so these market gains that you see across-the-board come ahead of federal reserve chair jay powell's big speech this friday. you heard charles say it matters. it's really important. he will be at the central bankers forum in jackson hole where he's expected to widely signal a september rate cut, and after the last and latest read on...
0
0.0
Aug 8, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
they've outperformed novo on a year to date basis by 2 to 1, and novo's out before amgen by 2 to 1.as trying to game when i could sell lilly. sounds like i'm not going to be able to, other than where you could have sold it for the last month or two. >> and by the way, they have a whole other pipeline of drugs coming. they have an alzheimer's drug, which is basically the only game in town, with ka essential la. >> i don't know -- it's like a -- >> i was told by the scientific officer it's pronounced, is kis sun la. >> kis sun la, yeah. >> i was like, okay, that makes it easier to think about it that way. >> okay. >> but they're very positive on that, because the fda was very positive in their discussions about how it's a finite amount of time that you take this. you take this for 12 months until the plaques are cleared and then you stop. and so, there -- it's not a forever drug, and so, it's more likely it will be reimbursed. >> that's the multibillion dollar question. >> exactly. >> but to me, you were -- you and i were talking about this today. >> when -- when? >> just, you know. c
they've outperformed novo on a year to date basis by 2 to 1, and novo's out before amgen by 2 to 1.as trying to game when i could sell lilly. sounds like i'm not going to be able to, other than where you could have sold it for the last month or two. >> and by the way, they have a whole other pipeline of drugs coming. they have an alzheimer's drug, which is basically the only game in town, with ka essential la. >> i don't know -- it's like a -- >> i was told by the scientific...
0
0.0
Aug 14, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen and merck at the bottom, but it's the all very, very softly, softly the dow up 12 points.t the s&p as well. see what we can see there. it's up a whole whopping 10 points, about two-tenths of a percent. and let's take a look at the big tech index, the nasdaq, that's doing a little better, up 533 points at 17,24is 1 -- 53 points. big tech, a mixed ball. amazon, microsoft, metaall moving modestly higher although amazon up nearly 10111% -- 1%. alphabet down three-quarters of a percent. talking about alphabet, let's take a look at google if we can. the justice department apparently considering breaking the company up. hmm. how does that happen, or lauren? lauren: yeah. and that's the question. how does that happen and what happens, is the problem. stock down a little bit. bloomberg is reporting that the most extreme remedy -- and this is the one that's being most discussed among the doj attorneys -- is forcing google to divest android. that's huge. it's on 2.5 billion devices. it could also force them to divest chrome, force google to share more of their data with competitors l
amgen and merck at the bottom, but it's the all very, very softly, softly the dow up 12 points.t the s&p as well. see what we can see there. it's up a whole whopping 10 points, about two-tenths of a percent. and let's take a look at the big tech index, the nasdaq, that's doing a little better, up 533 points at 17,24is 1 -- 53 points. big tech, a mixed ball. amazon, microsoft, metaall moving modestly higher although amazon up nearly 10111% -- 1%. alphabet down three-quarters of a percent....
0
0.0
Aug 20, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
right now, the leading winner is merck, nike, 3m, amgen, and s&p 500 we have at the top palo alto networksly now up 2.5%. darden restaurants, medtronic and edward life sciences on the list. nasdaq winners palo alto networks, 6% sirius xm radio, paypal, netflix is back on the list up six bucks at 6.94. the yield on the 10-year treasury well-below 4%. i keep saying that but it's true. 3.849% that's down. the price of gold this morning, well-over 2,500 bucks on ounce, 2,559. bitcoin moving to 60,000 bucks a coin, 60, 400. oil around $74 a barrel, 64.68. nat gas right around $2, 2.21. the average price for a gallon of regular down to 3.40 today but i always like to tell you in california the average price for regular is 4.59. coming up, did nancy pelosi confirm top democrats orchestrated biden leaving the race? listen. >> he made the decision for the country. my concern was not about the president. it was about his campaign. stuart: well what does newt gingrich think about all that? he's on the show a little bit. aoc had some harsh words for trump last night. >> we know that donald trump would
right now, the leading winner is merck, nike, 3m, amgen, and s&p 500 we have at the top palo alto networksly now up 2.5%. darden restaurants, medtronic and edward life sciences on the list. nasdaq winners palo alto networks, 6% sirius xm radio, paypal, netflix is back on the list up six bucks at 6.94. the yield on the 10-year treasury well-below 4%. i keep saying that but it's true. 3.849% that's down. the price of gold this morning, well-over 2,500 bucks on ounce, 2,559. bitcoin moving to...
0
0.0
Aug 15, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
look at amgen. you and i grew up in the '90s. that was go-go, mojo biotech.ow more of a value stock even though the stock is at or near all-time highs. we're talking about dividends and strong cash. air products is phenomenal company. charles: phenomenal company. >> nike has its issues. our analyst really real likes it in terms of unwinding management perspective. google we owned for 12 years. charles: no concerns about breakup? >> breakup could be positive if you take a look at some of the pieces. look at the youtube business. i said for a long time the youtube business, i think youtube will take over broadcast sports. that is the next big play. charles: you could have stopped at broadcast, not the rest of it, hate to say it. my man, good stuff, appreciate it. mark twain famously said the reports of my death are greatly exaggerated make like mark twain nvidia and a.i. are talking about that and where there could be some opportunities next. ♪. what does a good investment opportunity look like? at t. rowe price we let curiosity light the way. asking smart ques
look at amgen. you and i grew up in the '90s. that was go-go, mojo biotech.ow more of a value stock even though the stock is at or near all-time highs. we're talking about dividends and strong cash. air products is phenomenal company. charles: phenomenal company. >> nike has its issues. our analyst really real likes it in terms of unwinding management perspective. google we owned for 12 years. charles: no concerns about breakup? >> breakup could be positive if you take a look at...
0
0.0
Aug 30, 2024
08/24
by
FBC
tv
eye 0
favorite 0
quote 0
caterpillar, amazon, amgen, home depot on the list, all higher.autodesk, intel 's on the list, hewlett-packard, albemarle. and the nasdaq compos fit -- composite. monogo db, what is that? lauren: software company. stuart: intel's on that list, crowdstrike coming back to the tune of $10, 3.8%. >>> the 10-year treasury yield, where is that? it's going up slightly, 3.87. the price of gold sill at or very close to a record high, it's down $10. $2, 550. bitcoin flirting with $60,000, 59,5 at the moment. oil, mid $70 per barrel range, 74.222. it's down today. nat gas, $2.11. the average price for a gallon of regular gasoline, it keeps edging lower. you're now at $3.35, but in california it is stubbornly at $4.63. >>> coming up, an armed venezuelan migrant gang taking over entire apartment buildings colorado. one resident describing the fear of living there. >> every time i try to go to bed at night, we have to keep it like this so nobody can kick in the door. stuart: aurora, colorado, city council member is here with more detail. >>> harris putting the
caterpillar, amazon, amgen, home depot on the list, all higher.autodesk, intel 's on the list, hewlett-packard, albemarle. and the nasdaq compos fit -- composite. monogo db, what is that? lauren: software company. stuart: intel's on that list, crowdstrike coming back to the tune of $10, 3.8%. >>> the 10-year treasury yield, where is that? it's going up slightly, 3.87. the price of gold sill at or very close to a record high, it's down $10. $2, 550. bitcoin flirting with $60,000, 59,5...
0
0.0
Aug 7, 2024
08/24
by
CNNW
tv
eye 0
favorite 0
quote 0
this morning, brought to you by amgen learn more about thyroid disease at help my ted all right, this morning for the first time in 40 years, the epa is issuing an emergency ban. it is suspending the use of a common weedkiller known as dacthal. are dcpa. it is used on crops including broccoli, cabbage, and strawberries. the agency says, it poses serious risks to unborn babies of pregnant women who are exposed to the chemical, the epa he says it can cause problems with brain development and difficulty with motor skills and could contribute to low birth weight. sir. >> all right after saying he debate kamala harris on fox news or not at all, donald trump may have changed his mind again moments ago, trump called into fox and friends and hinted at a potential upcoming debate. with kamala harris. listen here and she's sort of a nasty person, but not a good good debater. >> but we'll see because will be debited debating or i guess in a pretty near future, it's going to be announced fairly soon. >> so the nasty woman line coming back again and when it comes to a potential debate between the
this morning, brought to you by amgen learn more about thyroid disease at help my ted all right, this morning for the first time in 40 years, the epa is issuing an emergency ban. it is suspending the use of a common weedkiller known as dacthal. are dcpa. it is used on crops including broccoli, cabbage, and strawberries. the agency says, it poses serious risks to unborn babies of pregnant women who are exposed to the chemical, the epa he says it can cause problems with brain development and...
0
0.0
Aug 20, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
we'll have amgen on, regeneron, roche.g people if you have $18 billion to spend to develop the brick and mortar foundries you need maybe you can compete against lilly. can you talk about your competitive edge versus others and also include the fact that the fda isn't looking to approve four or five companies if they have something that really works. >> sure, jim. yeah, so, of course, we welcome competition. it makes us all better. i think one of the things about our industry, but every other one, when we compete with each other we make better products and services for consumers. that's a good thick. that said i think we have an enormous advantage here and more coming. first of all, we first had phase 1 data on the drug in 2016. so people are getting excited about phase 1 data for these other companies, some with 16 or 20 patients. that is where we were exactly eight years ago. so it's a long time and a lot of effort to create, approve effectiveness and scale a product is where we are it t tirzeptide. probably more to do th
we'll have amgen on, regeneron, roche.g people if you have $18 billion to spend to develop the brick and mortar foundries you need maybe you can compete against lilly. can you talk about your competitive edge versus others and also include the fact that the fda isn't looking to approve four or five companies if they have something that really works. >> sure, jim. yeah, so, of course, we welcome competition. it makes us all better. i think one of the things about our industry, but every...
0
0.0
Aug 26, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
they will claim they've won many cases, be many of the high-profile ones, whether it's microsoft or amgeney have not proved victorious. >> this is what everyone should remember. they don't want a hag-way. that's what the safeway deal devolved to. hag-way is what they called them. my daughter had a hag-way across the street from her. come on. that's not good for the ftc. >> get ready. you got a "mad dash" coming up. stand something >> i don't think we're going to stand. maybe we'll stand. we'll see. you can take a closer look at my sneakers. take another look at futures. we get started with trading, less than ten minutes from now, benng otgiinanher big week here at the end of august. more "squawk on the street" straight ahead. at aes, our energy solutions have powered the world forward for more than 40 years. and as demand continues to scale, so do our solutions. introducing maximo - >> i don't think we're going to more "squawk on the street" max makes construction faster, safer and more cost effective than ever before. and with max doing the heavy lifting, even more people can join the te
they will claim they've won many cases, be many of the high-profile ones, whether it's microsoft or amgeney have not proved victorious. >> this is what everyone should remember. they don't want a hag-way. that's what the safeway deal devolved to. hag-way is what they called them. my daughter had a hag-way across the street from her. come on. that's not good for the ftc. >> get ready. you got a "mad dash" coming up. stand something >> i don't think we're going to...
0
0.0
Aug 1, 2024
08/24
by
CNBC
tv
eye 0
favorite 0
quote 0
you benefitted from antitrust action that you didn't think was going to be successful, amgen/horizon, do you view the potential for a change in administration here. is trump going to be better for your business or a potential harris administration better? >> well, putting aside who is better for the country, because i don't want to comment on that, i think that the current antitrust enforcement under the biden administration has been very zealous. if you look at lina khan and what she's done at the federal trade commission, i believe she's almost tried to do antitrust enforcement from a public policy perspective rather than a legal enforcement perspective. and that's created great -- tremendous uncertainty. and they have been able to profit from that uncertainty, so that's a good thing for our investors. at same time, she really has had a deterrence effect on seeing m&a transactions. so, if we have a harris administration, i would expect a continuation of what we've seen for the last four years. if we have a trump administration, i would -- lina khan certainly will not be chair of the
you benefitted from antitrust action that you didn't think was going to be successful, amgen/horizon, do you view the potential for a change in administration here. is trump going to be better for your business or a potential harris administration better? >> well, putting aside who is better for the country, because i don't want to comment on that, i think that the current antitrust enforcement under the biden administration has been very zealous. if you look at lina khan and what she's...